argenx SE | ARGX - Operating Profit

Stock Price
709.20
Daily Change
5.60 0.80%
Monthly
1.60%
Yearly
18.52%
Q1 Forecast
704.56

argenx SE reported $349.97M in Operating Profit for its fiscal quarter ending in September of 2025.





Operating Profit Change Date
AstraZeneca USD 2.97B 4.48B Dec/2025
Galapagos EUR -41.67M 15.36M Sep/2025
Genmab DKK 360M 172M Jun/2025
GlaxoSmithKline GBP 1.44B 1.35B Dec/2025
GRIFOLS EUR 352.11M 2.57M Sep/2025
Hikma Pharmaceutical USD 187M 95M Jun/2025
Qiagen NV USD 121.88M 15.41M Dec/2025
UCB EUR 1B 678M Dec/2024